Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
CopepodTCR enables efficient and accurate mapping of TCR—peptide specificities through optimized combinatorial peptide pooling coupled with Bayesian inference.
Abstract
T cell receptor (TCR) repertoire diversity enables the orchestration of antigen-specific immune responses against the vast space of possible pathogenic peptides. Identifying TCR/antigen specificity from the large TCR repertoire and antigen space is crucial for biomedical research.
We introduce copepodTCR, an open-access tool for the design and interpretation of high-throughput experimental assays to determine TCR/antigen specificity. copepodTCR implements a combinatorial peptide pooling scheme for efficient experimental testing of T cell responses against large overlapping peptide libraries, useful for “deorphaning” TCRs of unknown specificity. The scheme detects experimental errors and, coupled with a hierarchical Bayesian model for unbiased results interpretation, identifies the response-eliciting peptide for a TCR of interest out of hundreds of peptides tested using a simple experimental set-up.
Using in silico simulation, we demonstrated the applicability of our design scheme and the sensitivity of our results evaluation across varied experimental layouts and range of TCR-peptide activation signals. We experimentally validated our approach on a library of 253 overlapping peptides covering the SARS-CoV-2 spike protein, split across 12 pools. A single stimulation with combinatorial pools identified the correct epitope of two TCRs with known specificity and then deorphanized two SARS-CoV-2 associated TCRs shared among a large cohort of COVID-19 patients.
In conclusion, copepodTCR enables efficient and accurate mapping of TCR—peptide specificities through optimized combinatorial peptide pooling coupled with Bayesian inference. Beyond deorphanizing TCRs from established cell lines, we anticipate that copepodTCR can facilitate primary T cells deorphanization using single-sequencing as a read out, due to optimization of the pooling scheme, rational assignment of peptides and robust error-correction.
Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; Starr Centennial Scholarship; US National Institutes of Health Grants U01AI150747, R01AI136514, S10OD028632-01, 1R01AI167862; Simons Pivot Fellowship; National Natural Science Foundation of China Grant 62331002, National Science Foundation grant PHY-2210452.
Computational and Systems Immunology (COMP)
Development of effective vaccines and targeted immunotherapies for cancer, autoimmunity, allergy, and infectious diseases requires comprehensive understanding of functionality and antigenic specificity of involved T cell clones. A major technical challenge remains the high-throughput identification of antigen-speci...
E. Egorov, V. Kriukova, I. Shagina et al.· Scientific Reports· 0 citations
Decoding which antigens activate a given T cell receptor (TCR) is a central challenge in immunology. We present SEEKER, a functional genome-scale library-on-library screening platform built on three elements: a Jurkat-derived T-APC cell (TAPCell) that combinatorially expresses one TCR and one peptide–MHC drawn from sep...
Si-Cheng Li, Li Lin, Wen-Xu Wu et al.· bioRxiv· 0 citations
The LINC-seq platform, LINC-seq, recovered known cognate pairs from pooled libraries at up to 95% accuracy and performed simultaneous, library-on-library deep mutational scanning of both partners, and generalizes to any receptor-ligand pair whose trans-engagement drives a reporter.
L. Liu, Seung Won Shin, Kevin M. Joslin et al.· bioRxiv· 0 citations
MHC restriction — the requirement for αβ T cell receptors (TCRs) to recognize Major Histocompatibility Complex (MHC) molecules when presenting peptide antigens — is a pillar of adaptive immunity. Here, we provide direct structural evidence for TCR germline-encoded recognition of MHC molecules irrespective of antigenic...
Nan Wang, Marta T. Borowska, K. Jude et al.· bioRxiv· 0 citations
An integrated platform for generating human antibodies that mimic T-cell receptors and recognize peptide-HLA complexes with high specificity and affinity is developed, demonstrating superior performance compared to competitors’ TCRm antibodies.
Jennifer Watkins-Yoon, Wei-Cheng Lu, E. Petrunak et al.· mAbs· 0 citations
A mechanistic basis and a conceptual framework for the selection and optimization of TCRs for adoptive immunotherapy are provided for the selection and optimization of TCRs for adoptive immunotherapy.
Leire Oyon-Olea, Enric Vercher, M. G. Dichiara-Rodríguez et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.